Summary
Intravenous tumor cell injection and spontaneously metastasising transplantable tumors have been used as models for haematogenous tumor spread. To evaluate the validity of these two experimental approaches for the study of blood coagulability and metastases, the effect of anticoagulants on “secondary” tumor growth was investigated in both models and the results were compared. The B16 melanoma and the Lewis lung carcinoma in C57BL mice were employed throughout the study, and anticoagulation was rendered through the use of phenprocoumon, heparin and ancrod. All anticoagulants were capable of reducing lung colonies after i.v. tumor cell injection, whereas only phenprocoumon significantly diminished the formation of spontaneous metastases. A review of the current literature on anticoagulants and tumor dissemination and the observations described lead to the following conclusions: (1) Results from studies with i.v. introduced tumor cells cannot be extrapolated to spontaneously metastasising tumors. (2) Spontaneously metastasising tumors represent the preferable model for the study of antimetastatic effects of anticoagulants. (3) Little evidence exists to support the concept of the pathogenetic role of fibrin formation in the establishment of spontaneous metastases from blood-borne tumor cells. (4) Coumarin derivatives are potent antimetastatic drugs, their mode of action appears to be independent of their anticoagulant activity.
Similar content being viewed by others
References
Agostino D (1970) Prolonged coumarin treatment as an adjuvant to surgery in an experimental colon carcinoma. Tumori 56:165–174
Austin JP, Glaser EM (1969) Inhibition of experimental tumors by defibrinogenation. Clin Sci 37:878
Baserga R, Saffioti U (1955) Experimental studies on histogenesis of blood-borne metastases. Arch Pathol 59:26–34
Berkarda FB, D'Souza JP, Bakemeier RF (1974) The effect of anticoagulants on tumor growth and spread in mice. AACR Abstracts 15:396
Brown JM (1973) A study of the mechanism by which anticoagulation with warfarin inhibits blood borne metastases. Cancer Res 33:1217–1224
Cattan A, Pourny C, Carpentier Y, Cattan E, Barouh M (1977) Effect of hemostasis modifiers of the activity of VP16 213 on Lewis lung carcinomas. Biomedicine 27:203–208
Chew EC, Wallace AC (1976) Demonstration of fibrin in early stages of experimental metastases. Cancer Res 36:1904–1909
Chew EC, Wallace AC, Hunter E (1974) The use of immunoelectron microscopic technique in the study of experimental cancer metastases. In: Saunders JV, Goodchild DJ (eds) Proceedings of the 8th International Congress on Electron Microscopy, Canberra, vol 2. Australian Academy of Sciences, Canberra, p 502
Chmielewska J, Poggi A, Janik P, Latallo ZS, Donati MB (1978) Effect of defibrination with batroxobin on growth and metastases of JW sarcoma in mice. EORTC Metastases Project Group Meeting, London
Clifton EE, Grossi CE (1974) The rationale of anticoagulants in the treatment of cancer. J Med 5:107–113
Cotmore SF, Carter RL (1973) Mechanisms of enhanced intrahepatic metastasis in surfactant-treated hamsters; an electron microscopy study. Int J Cancer 11:725–738
Donati MB, Mussoni L, Poggi A, DeGaetano G, Garattini S (1978) Growth and metastasis of the Lewis lung carcinoma in mice defibrinated with batroxibin. Eur J Cancer 14:343–347
Edlis HE, Goudsmit A, Brindley C, Niemetz J (1976) Trial of heparin and cyclophosphamide (NSC-26271) in the treatment of lung cancer. Cancer Treat Rep 60:575–578
Frischkorn R, Rath W, Doench K (1976) Beeinflussung von Rattenschwanztumoren durch Antikoagulantien mit und ohne Bestrahlung. Strahlentherapie 151:214–221
Gastpar H (1972) Inhibition of cancer cell stickiness by anticoagulants, fibrinolytic drugs, and pyrimido-pyrimidine derivatives. Haematol Rev 3:1–51
Gropp C, Havemann K, Gassel WD, Hess F, Prignitz R, Schmidt M, Sodomann CP (1977) Kombinationschemotherapie bei Patienten mit metastasiertem Bronchialcarcinom. Z Krebsforsch 90:301–306
Hagmar B (1969) Effect of heparin, coumarin, and epsilon-amino-caproic acid (EACA) on spontaneous metastasis formation. Influence on the moment of metastasis formation. Possible cytotoxic effect of heparin and coumarin in blood. Pathol Eur 4:283–292
Hagmar B (1970) Tumor growth and spontaneous metastasis spread in two syngeneic systems. Influence of heparin, coumarin, and epsilon-amino-caproic acid (EACA). Acta Pathol Microbiol Scand 78a:131–142
Hagmar B, Boeryd B (1968) Effect of heparin, E-amino-caproic acid, and coumarin on tumor growth and spontaneous metastasis formation. Pathol Eur 3:509–520
Hilgard P (1977) Experimental vitamin K deficiency and spontaenous metastases. Br J Cancer 35:891–892
Hilgard P, Gordon-Smith EC (1974) Microangiopathic haemolytic anaemia and experimental tumourcell emboli. Br J Haematol 26:651–659
Hilgard P, Maat B (1979) The mechanism of lung tumour colony reduction caused by coumarin anticoagulation. Eur J Cancer 15:183–187
Hilgard P, Thornes RD (1976) Anticoagulants in the treatment of cancer. Eur J Cancer 12:755–762
Hilgard P, Schulte H, Wetzig G, Schmitt G, Schmidt CG (1977) Oral anticoagulation in the treatment of a spontaneously metastasising murine tumour (3LL). Br J Cancer 35:78–85
Hoover HC, Ketcham AS, Millar RC, Gralnick HR (1978) Osteosarcoma. Improved survival with anticoagulation and amputation. Cancer 41:2475–2480
Jones DS, Wallace AC, Fraser EE (1971) Sequence of events in experimental metastases of Walker 256 tumor: Light, immunofluorescent, and electron microscopic observations. J Natl Cancer Inst 46:493–504
Kodama Y, Tanaka K (1978) Effect of urokinase on growth and metastases of rabbit V2 carcinoma. Gann 69:9–18
Lacour F, Oberling Ch, Guerin M (1957) Influence de l'ethyldicoumarol sur l'evolution des metastases de epithelioma T8 chez le rat. Nouvelles Recherches. Bull Assoc Franc Cancer 44:88–91
Ludatscher RM, Luse SA, Suntzeff V (1967) An electron-microscopic study of pulmonary tumor emboli from transplantable morris hepatoma 5122. Cancer Res 27:1939–1952
Maat B (1978) Extra pulmonary colony formation after intravenous injection of tumour cells into heparin-treated animals. Br J Cancer 37:369–376
Maat B (1981) Selective macrophage inhibition abolishes warfarin-induced reduction of metastases. Br J Cancer 41:313–316
Retik AB, Arons MS, Ketcham AS, Mantel N (1962) The effect of heparin on primary tumors and metastases. J Surg Res 2:49–53
Ryan JJ, Ketcham AS, Wexler H (1968a) Warfarin treatment of mice bearing autochthonous tumors: Effect on spontaneous metastases. Science 162:1493–1494
Ryan JJ, Ketcham AS, Wexler H (1968b) Reduced incidence of spontaneous metastases with long-term coumarin therapy. Ann Surg 168:163–168
Salsbury AJ (1975) The significance of the circulating cancer cell. Cancer Treat Rev 2:55–72
Sindelar WF, Tralka TS, Ketcham AS (1975) Electron-microscopic observations or formation of pulmonary metastases. J Surg Res 18:137–161
Stenflo J (1976) A new vitamin K-dependent protein purification from bovine plasma und preliminary characterization. J Biol Chem 251:355–363
Szacki J, Lawinski M, Grzebieluch M (1973) Survival and frequency of pulmonary metastases in rats with implanted and removed Yoshida Sarcoma after treatment with e-aminocaproic acid and Sintrom. Arch Immunol Ther Exp 21:763–766
Warren S, Gates O (1936) The fate of intravenously injected tumour cells. Am J Cancer 27:485–492
Warren BA, Chauvin WJ, Philips J (1977) Blood-borne tumor emboli and their adherence to vessel walls. In: Day SB (ed) Cancer invasion and metastasis: Biologic mechanisms and therapy. Raven Press, New York, pp 187–197
Wexler H (1965) Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst 36:641–645
Wood S Jr, Holyoke ED, Yardley JH (1956) An experimental study of the influence of adrenal steroids, growth hormone, and anticoagulants on pulmonary metastasis formation in mice. Proc Am Assoc Cancer Res 2:157
Wood S (1958) Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. AMA Arch Pathol 66:550–568
Wood S, Holyoke ED, Yardley JH (1960/61) Mechanisms of metastasis production by blood-borne cancer cells. In: Proceedings of the 4th Canadian Cancer Research Conference, Honey Harbour-Ontario, June 12–16, vol 4, pp 167–223
Author information
Authors and Affiliations
Additional information
This study was performed in a programme of the EORTC Metastasis Project Group. Parts of the experiments were carried out at the “West German Cancer Centre”, University of Essen, FRG. Dr. P. Hilgard was supported by a grant from the “Deutsche Forschungsgemeinschaft”, Bonn-Bad Godesberg, FRG (Hi 213/3-4)
Rights and permissions
About this article
Cite this article
Maat, B., Hilgard, P. Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems. J Cancer Res Clin Oncol 101, 275–283 (1981). https://doi.org/10.1007/BF00410113
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00410113